Several prominent authors published a number of reviews on the hypotheses that may be suitable for the explanation of the remarkable tissue specificity of early cancers (HBOC) in BRCA1 and BRCA2 heterozygous carriers (Figure 1). The gene discussed is BRCA2; the disease is cancer.